Therachon
Total Raised
$100MInvestors Count
10Deal Terms
2Funding, Valuation & Revenue
5 Fundings
Therachon has raised $100M over 5 rounds.
Therachon's latest funding round was a Acquired for on May 8, 2019.
Therachon's latest post-money valuation is from May 2019.
Sign up for a free demo to see Therachon's valuations in May 2019 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
5/8/2019 | Acquired | 8 | ||||
8/9/2018 | Mezzanine | |||||
1/5/2017 | Series A - II | |||||
9/30/2015 | Series A | |||||
12/10/2014 | Seed VC |
Date | 5/8/2019 | 8/9/2018 | 1/5/2017 | 9/30/2015 | 12/10/2014 |
|---|---|---|---|---|---|
Round | Acquired | Mezzanine | Series A - II | Series A | Seed VC |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 8 |
Therachon Deal Terms
2 Deal Terms
Therachon's deal structure is available for 2 funding rounds, including their Acquired from May 08, 2019.
Round | Acquired | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acquired | |||||||||||||||
Series A |
Therachon Investors
10 Investors
Therachon has 10 investors. Pfizer invested in Therachon's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
5/8/2019 | 5/8/2019 | 1 Acquired | Corporation | New York | ||
12/10/2014 | 8/9/2018 | 4 Seed VC, Series A (2015), Series A - II (2017), Mezzanine (2018) | Venture Capital | France | ||
12/10/2014 | 8/9/2018 | 4 Seed VC, Series A (2015), Series A - II (2017), Mezzanine (2018) | Venture Capital | California | ||
Venture Capital | New York | |||||
Investment Bank | France |
First funding | 5/8/2019 | 12/10/2014 | 12/10/2014 | ||
|---|---|---|---|---|---|
Last Funding | 5/8/2019 | 8/9/2018 | 8/9/2018 | ||
Investor | |||||
Rounds | 1 Acquired | 4 Seed VC, Series A (2015), Series A - II (2017), Mezzanine (2018) | 4 Seed VC, Series A (2015), Series A - II (2017), Mezzanine (2018) | ||
Board Seats | |||||
Type | Corporation | Venture Capital | Venture Capital | Venture Capital | Investment Bank |
Location | New York | France | California | New York | France |
Therachon Acquisitions
1 Acquisition
Therachon acquired 1 company. Their latest acquisition was GlyPharma Therapeutic on October 09, 2018.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
10/9/2018 | Acquired | 4 |
Date | 10/9/2018 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources | 4 |
Loading...